As for miR-126, Fu and Tong found that lower miR-126 facilitated the ability of migration and invasion of trastuzumab-resistant breast cancer cells through targeting miR-126/PIK3R2 axis (Fu and Tong 2020). This evidence concerns the gene PIK3R2 and breast carcinoma.